McKesson (MCK) Falls More Steeply Than Broader Market: What Investors Need to Know
π McKesson (MCK) stock is expected to fall more steeply than the broader market if it misses earnings expectations.
π The company is set to release its quarterly results for the period ended March 2026 on May 7.
π° Analysts project MCK will post quarterly earnings of $11.56 per share, reflecting a +14.2% year-over-year increase.
π΅ Revenue estimates stand at $101.92 billion, representing a 12.2% growth from the same quarter last year.
π The consensus EPS estimate has been revised downward by 0.54% over the past 30 days due to reassessed analyst projections.
π MCK currently carries a Zacks Rank of #3 (Hold) and an Earnings ESP of -0.07%, suggesting analysts have turned bearish.
β οΈ A negative Earnings ESP reading combined with a Hold rank makes it difficult to predict that MCK will beat consensus EPS.
π In the last reported quarter, MCK delivered a +0.32% surprise by posting $9.34 per share against a $9.31 estimate.
π Over the past four quarters, MCK has beaten consensus EPS estimates on four separate occasions.
βοΈ Stock price movements are influenced by factors beyond earnings results, such as management discussion of business conditions.
π‘ The Zacks Earnings ESP model indicates that positive readings are strong predictors of beats but negative readings lack predictive confidence.
π§ͺ Staar Surgical (STAA) is another medical stock mentioned with expected EPS of $0.13 and revenues of $91.8 million.
π Staar Surgical shows a significantly lower Earnings ESP of -15.39% despite unchanged consensus estimates over the last 30 days.
π Staar Surgical has beaten consensus earnings three times over its last four reported quarters.
π Investors are encouraged to use the Zacks Earnings ESP Filter and Earnings Calendar for upcoming announcements.
π° The article notes that while betting on expected beats increases success odds, unforeseen catalysts can alter stock performance.
π Free analysis reports are available for both McKesson Corporation (MCK) and Staar Surgical Company (STAA).
π’ Both companies belong to the Zacks Medical - Dental Supplies industry as categorized in the article.
- McKesson is expected to deliver a year-over-year increase in earnings of +14.2% and revenue growth of 12.2% for the quarter ended March 2026.
- The company has a strong historical track record, beating consensus EPS estimates for all four quarters in the last reported period.
- Even with recent analyst estimate revisions, the consensus EPS expectation stands at $11.56 per share, representing significant growth over the prior year.
- McKesson carries a Zacks Rank of #3 (Hold), which is associated with better predictive power for positive earnings surprises according to proprietary research.
- The consensus EPS estimate for McKesson was revised 0.54% lower over the last 30 days, reflecting analysts reassessing their initial estimates and growing bearishness.
- McKesson's Most Accurate Estimate is lower than its Zacks Consensus Estimate, resulting in a negative Earnings ESP of -0.07%, which makes an earnings beat difficult to predict.
- The company currently carries a Zacks Rank of #3 (Hold), but this combination with a negative Earnings ESP further reduces the likelihood of a positive surprise compared to Strong Buy or Buy ratings.
- Investors face uncertainty as an aggregate change in estimates does not always reflect the specific direction of individual analyst revisions, adding noise to the outlook.
- Historical performance shows that McKesson may disappoint even with beats; some stocks lose ground despite beating expectations due to other disappointing factors mentioned on management calls.
- The article explicitly notes that McKesson does not appear a compelling earnings-beat candidate ahead of its May 7 report, suggesting significant downside risk if results deviate from the $11.56 per share expectation.